PRESS RELEASE

from Bonyf NV

bonyf NV: Delay in release of financial statements 2022

bonyf NV
bonyf NV: Delay in release of financial statements 2022

30-Jun-2023 / 14:35 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


   PRESS RELEASE

  Paris, 30 June 2023

 

 

 

Delay in release of financial statements 2022

 

 

 

 

Ghent (Belgium), 30 June 2023; bonyf NV (Mnemonic: MLBON), a leading manufacturer of oral  and denture care products announces its delay in the preparation and audit of the financial  statements for the 2022 financial year

  

bonyf NV’s, CEO and Founder, Mr Jean-Pierre Bogaert, released today an announcement to the company’s shareholders informing them that there will be a delay in the release of the audited financial statements of the company. 

Dear Shareholders,

We regret to inform you that bonyf NV was not yet able to publish its audited financial statements 2022.

We understand the importance of timely and transparent financial reporting, and as such, the audited financial statements will be available by 16 July 2023. The date of the General Meeting of Shareholders is 31 July 2023 at 10.00am.  

We apologize for any inconvenience caused, and appreciate your understanding and support. Should you have any questions or require further information, please do not hesitate to contact our Investor Relations department on investor@bonyf.com.

Thank you for your continued trust in bonyf NV.

Yours sincerely,

Jean-Pierre Bogaert

CEO bonyf NV

 

For more information, please visit www.bonyf.com.

 

    

bonyf’s strengths

  • Products with patented formulations
  • Produced in Switzerland compliant with stringent international quality regulations
  • Proven clinical efficacy
  • Commercial presence in 37 countries
  • Prospects for solid growth and rapid profitability 
  • A fast-growing oral and dental care market

 

 

 

 

About bonyf

Incorporated in 1979, bonyf specialises in the development, production and selling of cutting-edge oral & dental care  products. Through its unwavering commitment to innovation and continuous improvement, bonyf makes a real difference to  people suffering from dental and oral conditions. The company has its R&D facilities in Liechtenstein (in the renown dental  valley), a production plant in Switzerland and distributes its product range in 37 countries worldwide. Benefiting from seven patent protected formulations and products developed in-house, bonyf expects strong future development, driven by the  fast-growing oral and dental care market.

Learn more at https://bonyf.com

   

 

bonyf   

Jean-Pierre Bogaert     

investor@bonyf.com     

   

    

 

 

 


Regulatory filing PDF file

File: Bonyf - PR Delay in release of financial statements 2022 - 300623


Language:English
Company:bonyf NV
Doornzelestraat 114 D
9000 Gent
Belgium
Phone:+41 79 412 42 79
E-mail:president@bonyf.com
Internet:www.bonyf.com
ISIN:BE6333353298
Euronext Ticker:MLBON
AMF Category:Inside information / Other releases
EQS News ID:1670303
 
End of AnnouncementEQS News Service

1670303  30-Jun-2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1670303&application_name=news&site_id=symex
See all Bonyf NV news